Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Metz

Showing results (361-370 of 514) with videos related to

Pageof 52
Sort By:
Cancer|June 28, 2017
Survivorship and the chronic cancer patient: Patterns in treatment-related effects, follow-up care, and use of survivorship care plansMelissa A Frick, Carolyn C Vachani, Christina Bach, et al.
International Journal of MS Care|January 24, 2014
Perceived met and unmet health-care needs in a community population with multiple sclerosisScott B Patten, Jeanne V A Williams, Dina H Lavorato, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 13, 2001
Comparative treatment planning between proton and X-ray therapy in pancreatic cancerD C Hsiung-Stripp, J McDonough, H M Masters, et al.
Journal of the American Society of Nephrology : JASN|January 17, 2002
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritisFiona G Brown, David J Nikolic-Paterson, Prudence A Hill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2013
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromesH Kang, L M Metz, A L Traboulsee, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2015
Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapyEric Ojerholm, Maura L Kirk, Reid F Thompson, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayJ Bonneterre, H Coppens, L Mauriac, et al.
Journal of Gastrointestinal Oncology|November 30, 2017
Survivorship after treatment of pancreatic cancer: insights via an Internet-based survivorship care plan toolMelissa A Frick, Carolyn C Vachani, Margaret K Hampshire, et al.
Cancer|January 6, 2017
Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for careMelissa A Frick, Carolyn C Vachani, Margaret K Hampshire, et al.
Medical Physics|August 4, 2014
A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreasReid F Thompson, Sonal U Mayekar, Huifang Zhai, et al.
Pageof 52

Showing results (361-370 of 514) with videos related to

Sort By:
Pageof 52
Cancer|June 28, 2017
Survivorship and the chronic cancer patient: Patterns in treatment-related effects, follow-up care, and use of survivorship care plansMelissa A Frick, Carolyn C Vachani, Christina Bach, et al.
International Journal of MS Care|January 24, 2014
Perceived met and unmet health-care needs in a community population with multiple sclerosisScott B Patten, Jeanne V A Williams, Dina H Lavorato, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 13, 2001
Comparative treatment planning between proton and X-ray therapy in pancreatic cancerD C Hsiung-Stripp, J McDonough, H M Masters, et al.
Journal of the American Society of Nephrology : JASN|January 17, 2002
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritisFiona G Brown, David J Nikolic-Paterson, Prudence A Hill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2013
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromesH Kang, L M Metz, A L Traboulsee, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2015
Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapyEric Ojerholm, Maura L Kirk, Reid F Thompson, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayJ Bonneterre, H Coppens, L Mauriac, et al.
Journal of Gastrointestinal Oncology|November 30, 2017
Survivorship after treatment of pancreatic cancer: insights via an Internet-based survivorship care plan toolMelissa A Frick, Carolyn C Vachani, Margaret K Hampshire, et al.
Cancer|January 6, 2017
Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for careMelissa A Frick, Carolyn C Vachani, Margaret K Hampshire, et al.
Medical Physics|August 4, 2014
A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreasReid F Thompson, Sonal U Mayekar, Huifang Zhai, et al.
Pageof 52